2-Chloro-4-nitrophenylboronic acid - CAS 1436612-57-5
Catalog: |
BB062456 |
Product Name: |
2-Chloro-4-nitrophenylboronic acid |
CAS: |
1436612-57-5 |
Synonyms: |
B-(2-Chloro-4-nitrophenyl)boronic Acid |
IUPAC Name: | (2-chloro-4-nitrophenyl)boronic acid |
Description: | 2-Chloro-4-nitrophenylboronic Acid is a useful research chemical for organic synthesis and other chemical processes. |
Molecular Weight: | 201.37 |
Molecular Formula: | C6H5BClNO4 |
Canonical SMILES: | B(C1=C(C=C(C=C1)[N+](=O)[O-])Cl)(O)O |
InChI: | InChI=1S/C6H5BClNO4/c8-6-3-4(9(12)13)1-2-5(6)7(10)11/h1-3,10-11H |
InChI Key: | UQGPTZONRAXNDF-UHFFFAOYSA-N |
References: | Kamble, R. B., et al. New J. Chem., 43, 1632 (2019); Bommegowda, Y. K., et al. Chem. Lett., 45, 268 (2016). |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CA-3022395-A1 | Di-substituted pyrazole compounds for the treatment of diseases | 20160429 |
EP-3448851-A1 | Di-substituted pyrazole compounds for the treatment of diseases | 20160429 |
US-2019134017-A1 | Di-substituted pyrazole compounds for the treatment of diseases | 20160429 |
WO-2017190086-A1 | Di-substituted pyrazole compounds for the treatment of diseases | 20160429 |
AU-2017258781-B2 | Di-substituted pyrazole compounds for the treatment of diseases | 20160429 |
CN-109476635-B | Disubstituted pyrazoles for treatment of diseases | 20160429 |
AU-2017258781-C1 | Di-substituted pyrazole compounds for the treatment of diseases | 20160429 |
AU-2013337370-A1 | Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway | 20121105 |
AU-2013337370-B2 | Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway | 20121105 |
CA-2890002-A1 | Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway | 20121105 |
Complexity: | 198 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 201.0000155 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 201.0000155 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 86.3Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
-
Catalog: BB061033
((2R,5S,10aS,10bS)-10b-Hydroxy-5-isopropyl-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)carbamic Acid Benzyl Ester
Detail
-
Catalog: BB075348
((2S,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, sodium salt
Detail
-
Catalog: BB067784
((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methanamine
Detail
-
Catalog: BB069927
((2R,4S)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate
Detail
-
Catalog: BB071775
((1R,4R)-4-(((tert-butyldimethylsilyl)oxy)methyl)cyclohexyl)methanol
Detail
-
Catalog: BB072640
((2R,3S,4R,5R)-5-(4-(Benzyloxy)-2-oxopyridin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl bis(2-cyanoethyl) Phosphate
Detail
-
Catalog: BB074213
((2R,3S,4R,5R,6R)-5-Acetamido-3,4-dihydroxy-6-(2-(trimethylsilyl)ethoxy)tetrahydro-2H-pyran-2-yl)methyl 4-Methylbenzenesulfonate
Detail
-
Catalog: BB069924
((2S,4S)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS